• 터널과지하공간
• /
• 제32권3호
• /
• pp.173-193
• /
• 2022

본 연구에서는 GMG (Global Mining Guidelines Group)에서 개발한 광업 분야 가이드라인을 중심으로 스마트 마이닝 기술 국제 표준화 동향을 분석하였다. GMG는 글로벌 광업 커뮤니티를 하나로 묶는 비영리 단체이며, 광업의 안전과 혁신, 지속가능성을 제고시키기 위한 목적으로 설립되었다. 현재 GMG의 실무그룹은 인공지능, 자산관리, 자율 채광, 사이버 보안, 데이터 접근 및 사용/상호 운용성, 전기화, 광물 처리, 지하 채광, 지속가능성 실무그룹으로 구성되어 있다. 스마트 마이닝 기술과 관련한 가이드라인 개발 프로젝트는 인공지능, 자율 채광, 사이버 보안, 데이터 접근 및 사용/상호운용성, 지하 채광 실무그룹에서 진행되고 있다. 2022년 4월 현재 8종의 스마트 마이닝 관련 가이드라인은 사전 착수, 착수, 가이드라인 정의, 콘텐츠 생성, 기술 수정, 레이아웃 및 최종 검토, 투표 과정을 거쳐 출판되었다. GMG에서 출판한 가이드라인은 국내 스마트 마이닝 기술 표준 개발에 있어 중요한 참고 자료가 될 수 있을 것이라 판단된다.

• Journal of Digestive Cancer Research
• /
• 제4권1호
• /
• pp.21-28
• /
• 2016

간세포암종은 만성 간질환과 간경변증을 동반하는 경우가 많고, 예후에 종양 인자 이외에도 잔존 간 기능이 주요한 영향을 미친다. 또한, 간세포암종에 대한 고위험인자를 가진 경우 특정한 영상 소견(예: 고혈관성)을 보이면, 조직검사 없이도 비침습적인 진단이 가능하다. 다른 고형암에서와 마찬가지로 수술적 절제, 방사선치료, 항암치료 등의 치료가 시행되기도 하지만, 간세포암종에서만 이루어진다고도 할 수 있는 간이식, 경동맥화학색전술, 고주파열치료술과 같은 치료 방법들이 시행되기도 한다. 종양의 다양성, 치료 방법의 다양성, 사회적 여건(의료 보건 체계, 의료 자원의 가용성 등) 등을 반영하며 여러 간세포암종 가이드라인들이 발표되어 왔으며, 각 가이드라인들은 여러 측면에서 유사하면서도 서로 상이하기도 하다. 본고에서는 다음의 간세포암종 진료 가이드라인들을 살펴보고, 가이드라인들의 특징과 앞으로 가이드라인에서 다루어야 할 부분 등에 대하여 논하고자 한다.

• Korean Circulation Journal
• /
• 제53권7호
• /
• pp.452-471
• /
• 2023

The Korean Society of Heart Failure (KSHF) Guidelines provide evidence-based recommendations based on Korean and international data to guide adequate diagnosis and management of heart failure (HF). Since introduction of 2017 edition of the guidelines, management of advanced HF has considerably improved, especially with advances in mechanical circulatory support and devices. The current guidelines addressed these improvements. In addition, we have included recently updated evidence-based recommendations regarding acute HF in these guidelines. In summary, Part IV of the KSHF Guidelines covers the appropriate diagnosis and optimized management of advanced and acute HF.

• Korean Circulation Journal
• /
• 제53권4호
• /
• pp.217-238
• /
• 2023

The Korean Society of Heart Failure (KSHF) guidelines aim to provide physicians with evidence-based recommendations for the management of patients with heart failure (HF). After the first introduction of the KSHF guidelines in 2016, newer therapies for HF with reduced ejection fraction, HF with mildly reduced ejection fraction, and HF with preserved ejection fraction have since emerged. The current version has been updated based on international guidelines and research data on Korean patients with HF. Herein, we present Part II of these guidelines, which comprises treatment strategies to improve the outcomes of patients with HF.

• 한국임상약학회지
• /
• 제28권2호
• /
• pp.146-153
• /
• 2018

Objective: Multi-regional clinical trials have been widely used for accelerating global drug development by multinational pharmaceutical companies. In this study, we aimed to review and analyze the international trends in regulations and guidelines on multi-regional clinical trials by regulatory authorities and international organizations, such as International Conference on Harmonisation, for referring to policies, including development of domestic guidelines for multi-regional clinical trials. Methods: The policies, regulations, and guidelines published by the US Food and Drug Administration, European Medicines Agency, Pharmaceuticals and Medical Devices Agency (Japan), and China Food and Drug Administration were searched, and the International Conference on Harmonisation E17 draft guideline was reviewed. Results: The regulatory authorities in developed countries have developed and implemented regulations and guidelines on multi-regional clinical trials to promote simultaneous global drug development and evaluate the regional differences in drug safety and efficacy. International Conference on Harmonisation developed the draft guideline for planning/designing of multi-regional clinical trials in 2016, which recommends the general principles for strategy-related issues and design of multi-regional clinical trials, and for protocol-related issues, such as consideration of regional variability, subject selection, dose selection, endpoints, comparators, overall sample size, allocation to regions, collecting information on efficacy and safety, and statistical analysis. Conclusion: It is important to understand the international regulatory requirements for designing and planning of multi-regional clinical trials for global drug development. Moreover, it is necessary to prepare multi-regional clinical trial guidelines in accordance with the Korean regulation for clinical trials and drug administration.

• 한국치위생학회지
• /
• 제14권2호
• /
• pp.241-250
• /
• 2014

Objectives : The purpose of the study was to examine the ethical requirements for the protection of human subjects in the publication guidelines of dental health journals. Methods : The guidelines of 27 dental health journals were reviewed to determine ethical standards alone, with Helsinki Declaration, by an institutional review board (IRB), informed consent, protection of subject privacy and confidentiality, and no conflicts of interest. Results : 1. Dentistry journals listed on National Research Foundation of Korea had a conflict of interest disclosure provisions of the contribution(76.9%) and the IRB approval(61.5%). 2. Half of the dental health journals were not listed on National Research Foundation of Korea Society but they agreed the advance posting provisions. 3. Dental hygiene journals provide 100% of ethics alone and receive 75% of IRB in the papers. 4. Dental health and dental hygiene journals have conflicts of interest disclosure regulations(59.2%) and IRB approval(51.8%). 5. There existed statistically significant differences between the dental health journals whether they were listed on the human subjects and ethical standards for protection in National Research Foundation of Korea or not. Conclusions : While the publication guidelines of dental health journals have followed to a greater extent in recent years, there is still a need for further instructions to ensure that the authors satisfy all ethical requirements in conducting research on human subjects. IRB approval for dental journals must be standardized and reinforced reflecting the characteristics of each journals. The researchers should obey the code of ethics suitable for education and the editors must review the paper continuously.

• Korean Journal of Acupuncture
• /
• 제36권1호
• /
• pp.19-35
• /
• 2019

Objectives : The purpose of this study is to review which acupoints and meridians are selected to treat visceral pain in articles published in international journals and to investigate quality of reporting acupuncture intervention according to the STRICTA guidelines. Methods : Electrical and hand search were conducted in PubMed, EMBASE, MEDLINE, and Cochrane Library for acupuncture studies on visceral pain in human and animals. Reporting quality of intervention was evaluated using the revised STRICTA guidelines. Results : We included 51 articles (7 clinical studies and 44 animal studies) in this study. The most frequently adopted meridians and acupoints were Stomach meridian, Spleen meridian, Conception Vessel meridian, and ST36, CV4, SP6, LI4, PC6, SP9, ST25, ST37 in clinical studies. In animal studies, Stomach meridian, Conception Vessel meridian, Pericardium meridian and ST36, ST37, CV12, PC6 were most frequently used. Animal studies showed significantly lower quality of reporting compared to clinical studies. According to the analysis on the effect of year of publication of articles, announcement of STRICTA guidelines did not improve the quality of reporting for studies on visceral pain. Conclusions : These results suggest that both proximal and distal acupoints based on meridian theory were used to study the underlying mechanisms of visceral pain both in human and animal studies. Guidelines of acupuncture intervention reporting for animal study is necessary to improve the quality of evidence, and it will also allow us the integrative understanding of the mechanisms and clinical effects of acupuncture treatment in human and animal.

• The Korean Journal of Pain
• /
• 제30권1호
• /
• pp.18-33
• /
• 2017

As the treatment of chronic non-cancer pain gradually increases, clinicians have more opportunities to encounter opioid prescription. However, guidelines for prescribing opioids for chronic non-cancer pain have never been published in Korea. The present guidelines were prepared by reviewing various research data. In cases in which the data were insufficient, recommendations were presented following discussion among experts affiliated with the Opioids Research Group in the Korean Pain Society. The present guidelines may need to be continuously revised and amended as more clinical evidence is acquired.

• Pediatric Infection and Vaccine
• /
• 제27권1호
• /
• pp.24-34
• /
• 2020

대한소아감염학회와 질병관리본부 중앙방역대책본부는 소아청소년 코로나바이러스감염증-19 (coronavirus disease 2019, COVID-19) 대응지침을 발표하였다. 사례정의 및 조치사항을 신생아, 영아, 소아청소년에 맞추어 정리하였으며, 보호자 관리에 대한 지침을 마련하였다. 본 종설에서는 우리나라 소아청소년 COVID-19 대응지침의 내용을 소개하고자 한다.

• 약학회지
• /
• 제47권4호
• /
• pp.244-251
• /
• 2003

Asthma is a chronic inflammatory disease of the airway and the prevalence rate is increasing. As the burden of asthma to the society is significant due to the increasing hospital admissions and emergency visits, National Heart, Lung and Blood Institute (NHLBI, USA) and World Health Organization (WHO) have developed comprehensive guidelines to help clinicians and patients make appropriate decisions about asthma care. The aim of study was to analyze the pattern of asthma prescriptions based on the national asthma guidelines for the patients visiting primary health care providers. Prescription data for asthma were obtained from the Korean National Health Insurance claims database of January 2002. Ten percent of the primary health care providers were sampled based on their specialty areas, and 20％ of the claim cases were randomly chosen. Study results showed that prescription rate for oral beta-2 agonists was 44.3％, and that for oral theophylline was 46.9％. Oral steroids were prescribed for the 28.2％ of the claims. Utilization of inhalers was low for both bronchodilators (20.3％, beta-2 agonists inhalers), and steroids (8.4％ steroids inhalers). Bronchodilators were more preferred to the longterm anti-inflammatory controllers among the primary health care providers. Prescription rate for antibiotics was 46.0％ for asthmatic patients. Also gastrointestinal drugs were prescribed for 59.0％, antitussives 65.3％, antihistamines 25.3％ and analgesics 29.4％, respectively. This study presented that the prescribing pattern of the primary health care providers for the asthma was quite different from the national and international guidelines. More efforts need to be made to reduce the gap between the present pattern of asthma prescription and the guidelines.